Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has emerged as one of the most effective weight loss medications available, with clinical trials showing average weight reductions of 15% over 68 weeks. This glucagon-like peptide-1 (GLP-1) receptor agonist works by slowing stomach emptying and signaling fullness to your brain, reducing appetite naturally. PlexusDx provides access to compounded semaglutide injections through licensed 503A pharmacies across all 50 states.
How Semaglutide Injections Work for Weight Loss
Semaglutide is a synthetic version of GLP-1, a hormone your body produces naturally after eating. When you inject semaglutide once weekly, it binds to GLP-1 receptors throughout your digestive system and brain, triggering signals that reduce hunger and increase feelings of fullness. This mechanism helps you eat less without relying on willpower alone, making sustainable weight loss more achievable.
The medication also slows how quickly food moves through your stomach, which extends the sensation of satisfaction after meals. Additionally, semaglutide may improve your body's metabolic rate and reduce cravings for high-calorie foods. Most patients begin experiencing appetite suppression within the first week, though maximum effects develop over several weeks as your dose is optimized.
Compounded vs. Brand-Name Semaglutide Injections
Brand-name semaglutide (Ozempic for diabetes, Wegovy for weight loss) is manufactured by Novo Nordisk and typically requires insurance or significant out-of-pocket costs. PlexusDx offers compounded semaglutide injections prepared by licensed 503A compounding pharmacies, providing the same active ingredient at substantially lower costs without insurance requirements. Compounded medications must meet the same purity, potency, and sterility standards as brand-name products.
The key difference is that compounded semaglutide is customized by a licensed pharmacist rather than mass-produced in a pharmaceutical facility. PlexusDx works with certified compounding pharmacies that undergo regular quality audits and maintain strict pharmaceutical standards. Your dose may need to go up as your treatment progresses, but your price won't—PlexusDx charges a flat monthly rate regardless of dose level.
PlexusDx Semaglutide Injection Pricing and Access
PlexusDx compounded semaglutide injections start at $149 per month across all commitment tiers, with no insurance required and no membership fees. This flat pricing structure means your monthly cost remains the same whether you're starting at a lower dose or adjusting upward during your treatment journey. All medications are shipped directly to your home from licensed 503A compounding pharmacies serving all 50 states.
Payment is flexible: PlexusDx accepts HSA and FSA accounts, making semaglutide therapy even more affordable for eligible patients. If you'd like personalized guidance on your medication choice, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to assess how your unique genetics influence your response to GLP-1 therapy and other peptide-pathway medications.
What to Expect During Semaglutide Weight Loss Treatment
Most patients begin with a low starting dose that's gradually increased every week or two until reaching their therapeutic dose. During the first month, you may experience reduced appetite, mild nausea, or changes in digestion—these side effects typically improve as your body adjusts. Consistent weekly injections work best when paired with balanced nutrition and regular movement, though the medication itself does much of the work by controlling hunger signals.
Weight loss typically becomes noticeable within 2-4 weeks, with average patients losing 1-2 pounds per week during the first three months. Your PlexusDx care team monitors your progress and adjusts your dose if needed to maximize results while minimizing side effects. Most patients continue therapy for 6-12 months or longer, depending on their weight loss goals and how well they tolerate the medication.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide from PlexusDx the same as brand-name Ozempic or Wegovy?
PlexusDx compounded semaglutide contains the identical active ingredient as Ozempic and Wegovy, prepared by licensed 503A compounding pharmacies. The main difference is cost and accessibility: compounded versions start at $149/month without insurance requirements, while brand-name options often cost $900-$1,500 monthly. Both are effective for weight loss when dosed appropriately.
How much weight can I expect to lose with semaglutide injections?
Clinical trials show patients lose an average of 15% of their starting body weight over 68 weeks using semaglutide. Individual results vary based on your starting weight, metabolism, diet, and activity level. PlexusDx personalizes your treatment plan to maximize your results while keeping you comfortable during the weight loss process.
Can I use PlexusDx semaglutide if I don't have insurance?
Yes—PlexusDx requires no insurance and charges a flat rate of $149/month for compounded semaglutide injections. HSA and FSA accounts are accepted, and all medications are shipped directly to your home from licensed 503A pharmacies across all 50 states.
What side effects should I expect from semaglutide injections?
Common side effects include mild nausea, reduced appetite (which is the intended effect), constipation, or slight dizziness during dose increases. Most side effects improve within 1-2 weeks as your body adjusts. Serious side effects are rare but may include severe nausea, pancreatitis symptoms, or gallbladder issues—contact your provider immediately if you experience these.
Does PlexusDx offer genetic testing to predict how I'll respond to semaglutide?
Yes—PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) that analyzes 14 pathways and 150+ genetic insights, including variants like GLP1R rs6923761 that influence your semaglutide response. This test helps optimize your personalized treatment plan for better results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic for Weight Loss Bad for You? A Comprehensive Exploration
Navigating Weight Loss: Can You Take Ozempic If You Had Gallbladder Removed?